Sexually transmitted diseases in injection drug users

Infectious Disease Clinics of North America

Volumn 16, Issue 3, 2002, Pages 771-780

  Kanno, Mettassebia B ^a   Zenilman, Jonathan ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; CONDYLOMA; GONORRHEA; HERPES SIMPLEX; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; VAGINITIS; VIRUS TRANSMISSION;

ADULT; FEMALE; HUMANS; MALE; PREVALENCE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SEXUALLY TRANSMITTED DISEASES, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 0036736645     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(02)00011-9     Document Type: Review

References (33)

1. Zinberg NE. Drug, set, and setting. The basis for controlled intoxicant use. New Haven (CT): Yale University Press; 1984.
2. Rolfs R, Schmid GP. United States syphilis epidemic-reason for optimism. New York State Journal of Medicine 1991;91(12):522-4.
3. Centers for Disease Control. Primary and secondary syphilis-United States 1999. MMWR Morb Mortal Wkly Rep 2001;50(07):1113-7.
4. Lopez-Zetina J, Ford W, Weber M, et al. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-1996. Sex Transm Infect 2000;76:462-9.
5. Gourevitch MN, Hartel D, Schoenbaum EE, et al. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NewYork. Am J Public Health 1996;86:1112-5.
6. Ochelska B, Przedpelska G. The course of early syphilis in morphine base-dependent rabbits. Przeglad Dermatologiczny 1989;76(3):247-55.
7. Nelson KE, Vlahav D, Cohn S, et al. Sexually transmitted diseases in a population of injection drug users-association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis 1991;164:457-63.
8. Centers for Disease Control. Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47(RR-1):1-118.
9. Paschane DM, Fisher DG, Cagle HH, et al. Gonorrhea among drug users: an Alaskan versus a national sample. Am J Drug Alcohol Abuse 1998;24(2):285-97.
10. Upchurch DM, Brady ME, Reichart CA, et al. Behavioral contributions to acquisition of gonorrhea in patients attending an inner city sexually transmitted disease clinic. J Infect Dis 1990;161:938-41.
11. Cohen MS. Sexually transmitted diseases enhance HIV transmission-no longer a hypothesis. Lancet 1998;352(9145):2026.
12. Kelly PJ, Bair RM, Baillargeon J, et al. Risk behaviors and the prevalence of chlamydia in a juvenile detention facility. Clin Pediatr (Phila) 2000;39(9):521-7.
13. Swanson JM, Remy L, Chelitz WC, et al. Illicit drug use among young adults with genital herpes. Public Health Nurs 1993;10(3):197-203.
14. Surveillance and statistics. Tracking the hidden epidemics and trends in sexually transmitted diseases in the United States. Atlanta (GA): Centers for Disease Control, 2000. p. 1-32.
15. Krieger JN, Aldete JF. Trichomonas vaginalis and Trichomoniasis. In: Holmes KK, Sparling PF, PerAnders M, et al. Sexually transmitted diseases, 3rd edition. McGraw-Hill; 1999. p. 587-604.
16. Krieger JN. Urologic aspects of trichomoniasis. Investigative Urology 1981;18(8):411-7.
17. Bachmann LH, Lewis I, Allen R, et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health 2000;90(10):1615-8.
18. Miranda HE, Vargas PM, St Louis ME, et al. Sexually transmitted diseases among female prisoners in Brazil: prevalence and risk factors. Sex Transm Dis 2000;27(9):491-5.
19. Hillier SL, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, PerAnders M, et al, editors. Sexually transmitted diseases. 3rd edition. McGraw-Hill; 1999. p. 563-86.
20. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and the risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180(6):1863-8.
21. Avonts D, Sercu M, Heyerick P, et al. Incidence of uncomplicated genital infections in women using oral contraceptives or intrauterine devices: a prospective study. Sex Transm Dis 1990;17(1):23-9.
22. Barbone F, Austin H, Louv WC, et al. A follow-up study of methods of contraception, sexual activity and rates of trichomonas, candida, and bacterial vaginosis. Am J Obstet Gynecol 1990;163(2):510-4.
23. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996;174(5):1058-63.
24. Rajamanoharan S, Low N, Jones SB, et al. Bacterial vaginosis, ethnicity, and the use of genital cleaning agents: a case-control study. Sex Transm Dis 1999;26(7):404-9.
25. Corey L, Wald A. In: Genital herpes. Holmes KK, Sparling PF, PerAnders M, et al, editors. Sexually transmitted diseases. 3rd edition. McGraw-Hill; 1999. p. 285-312.
26. Hwang LY, Ross MW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000;31(4): 920-6.
27. Friedman SR, Curtis R, Jose B, et al. Sex, drugs, and infections among youth. Parentally and sexually transmitted diseases in a high risk neighborhood. Sex Transm Dis 1994;27: 322-6.
28. Hook 3rd EW, Cannon RO, Nahmias AJ, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992;165(2):251-5.
29. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex type II in HIV-seropositive women. Ann Intern Med 1995;123(11):845-7.
30. Burk RD, Ho GY, Beardsley L, et al. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infections in young women. J Infect Dis 1996;174:679.
31. van Doornum GJ, Prins M, Juffermans LH, et al. Regional distribution and incidence of human papilloma virus infections among heterosexual men and women multiple sex partners-a prospective study. Genitourinary Medicine 1994;70(4):240-6.
32. de Sanjose S, Vargas I, Paz Canadaz M, et al. Human papillomavirus and human immunodeficiency virus infections and risk factors for cervical cancer in women prisoners. Med Clin (Barc) 2000;115(3):81-4.
33. Kiviat NB, Koutsky LA, Paavonen J. Cervical neoplasia and other STD-related genital tract neoplasms. In: Holmes KK, Sparling PF, PerAnders M, et al, editors. Sexually transmitted diseases. 3rd edition. McGraw-Hill; 1999. p. 811-31.